semaglutide essence trial Phase 3 results demonstrating statistically significant and superior improvements with 2.4 mg in people with MASH presented at AASLD 2024 Semaglutide 2.4mg Achieves 63% MASH
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9

























